CPT code 95926 identifies a short-latency somatosensory evoked potential (SSEP) study performed by stimulating lower-limb peripheral nerves or skin sites and recording central nervous system responses. This neurophysiologic diagnostic test is used to evaluate sensory pathway integrity and can inform care for patients with suspected spinal cord, peripheral nerve, or central nervous system disorders. Nationally, SSEP testing contributes to diagnostic workflows in neurology, neurosurgery, and intraoperative monitoring contexts.

Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find an overview of clinical indications and service settings, common payer coverage considerations, and benchmarking of utilization where available. The publication also highlights coding context, typical sites of service (hospital outpatient departments, ambulatory surgical centers, and neurodiagnostic labs), and practical coding notes relevant to documentation and billing.

The content is intended to help revenue cycle, billing, and clinical teams understand the clinical purpose of CPT code 95926, how it fits into neurodiagnostic service lines, and where to look for payer-specific coverage policies and reimbursement guidance. Data not available in the input will be noted where applicable.